Furthermore, KIF11 inhibition could completely suppress the growth of classic (neuroendocrine) SCLC cells, namely the SCLC-A and SCLC-N subtypes, which account for ~85% of SCLC cases [6]. The gene discussed is KIF11; the disease is small cell lung carcinoma.